DAFTAR PUSTAKA

(1)

34

1. World Health Organization. WHO _ Cardiovascular diseases (CVDs) [Internet]. Cardiovascular diseases (CVDs). World Health Organization;

2016 [cited 2019 Feb 8]. Available from:

https://www.who.int/cardiovascular_diseases/en/

2. Pusdatin. Situasi Kesehatan Jantung. 2013.

3. Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mahonen M, Blackett KN, et al. World Health Organization definition of myocardial infarction:

2008-09 revision. Int J Epidemiol. 2011;40(1):139–46.

4. Organización Mundial de la Salud. Prevention of Recurrences of

Myocardial Infarction and Stroke Study. WHO [Internet]. 2013 [cited 2019 Feb 8]; Available from:

https://www.who.int/cardiovascular_diseases/priorities/secondary_preventi on/country/en/index1.html

5. Leonard S. Lilly. Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty. 6th, illustr ed. Lilly LS, editor.

Wolters Kluwer, 2015; 2016. 467 p.

6. Ferrara LA, Russo BF, Gente R, Esposito G, Rapacciuolo A, De Simone G.

STEMI and NSTEMI: A mono versus a multivessel disease? Int J Cardiol [Internet]. 2013;168(3):2905–6. Available from:

http://dx.doi.org/10.1016/j.ijcard.2013.03.154

7. Grant W Reed, Jeff rey E Rossi CPC, Acute. Acute myocardial infarction.

Lancet. 2017;389:197.

8. Samsu N, Sargowo D. Sensitivitas dan Spesifisitas Troponin T dan I pada Diagnosis Infark Miokard Akut. Maj Kedokt Indones. 2007;57(10):363–72.

9. Mythili S, Malathi N. Diagnostic markers of acute myocardial infarction (Review). Biomed Reports [Internet]. 2015;743–8. Available from:

http://www.spandidos-publications.com/10.3892/br.2015.500 10. Wu AHB. Release of cardiac troponin from healthy and damaged

myocardium. Front Lab Med [Internet]. 2017;1(3):144–50. Available from:

http://linkinghub.elsevier.com/retrieve/pii/S2542364917300997

11. Henrie N, Harvell B, Ernst AA, Weiss SJ, Oglesbee S, Sarangarm D, et al.

Comparison of QTc and Troponin Levels in ST Elevation MIs Compared with Non-ST Elevation MIs. South Med J [Internet]. 2017 Mar [cited 2019 Feb 25];110(3):210–6. Available from:

http://www.ncbi.nlm.nih.gov/pubmed/28257548

12. Vogiatzis Ii, Dapcevic I, Datsios A, Koutsambasopoulos K, Gontopoulos A, Grigoriadis and. A Comparison of Prognostic Value of the Levels of ProBNP and Troponin T in Patients with Acute Coronary Syndrome

::repository.unisba.ac.id::

(2)

35

(ACS). Med Arch [Internet]. 2016;70(4):269. Available from:

http://www.scopemed.org/fulltextpdf.php?mno=237498

13. Moore KL, Dalley AF, Agur AMR. Moore Clinically Oriented Anatomy.

Lippincott Williams & Wilkins, a Wolters Kluwer business. 2014. 1134 p.

14. Fuster V, Jason C. Kovacic. Acute Coronary Syndromes: Pathology, Diagnosis, Genetics, Prevention and Treatment. 2012;1(3):233–45.

15. Themistocleous, I.-C., Stefanakis, M., Douda H. Coronary Heart Disease Part I : Pathophysiology and Risk Factors. J Phys Act Nutr Rehabil. 2017;

16. Daga LC, Kaul U, Mansoor A. Approach to STEMI and NSTEMI. J Assoc Physicians India. 2011;59(12 SPEC. ISSUE):19–25.

17. Illingworth DR. New risk factors for coronary heart disease. In: American Journal of Medicine. 1999. p. 19–21.

18. Barstow C, Rice M, McDivitt JD. Acute coronary syndrome: Diagnostic evaluation. Am Fam Physician. 2017;95(3):170–7.

19. Wells SM, Sleeper M. Cardiac troponins. J Vet Emerg Crit Care.

2015;18(3):235–45.

20. Sharma D, Gupta P, Srivastava S, Jain H, Sharma D, Med JA. Sensitivity and specificity of cardiac troponin-T in diagnosis of acute myocardial infarction. Int J Adv Med. 2017;4(1):244–6.

21. Kathleen Pagana Timothy Pagana Theresa Pagana. Mosby’s Diagnostic and Laboratory Test Reference. 12th Editi. Elsevier; 2014. 1104 p.

22. Neumann JT, Sörensen NA, Schwemer T, Ojeda F, Bourry R, Sciacca V, et al. Diagnosis of myocardial infarction using a high-sensitivity Troponin i 1- hour algorithm. JAMA Cardiol. 2016;1(4):397–404.

23. Susilo C. IDENTIFIKASI FAKTOR USIA, JENIS KELAMIN DENGAN LUAS INFARK MIOKARD PADA PENYAKIT JANTUNG KORONER (PJK) DI RUANG ICCU RSD DR. SOEBANDI JEMBER Cipto Susilo*.

Indones J Heal Sci. 2015;6(1):1–7.

24. Moshki M, Zareie M, Hashemizadeh H. Sex differences in Acute Myocardial Infarction. Nurs Midwifery Stud. 2015;4(1):4–5.

25. Nugroho IS. Perbedaan Kadar SGOT pada Pasien ST-Elevasi Miokard Infark (STEMI) dan Non-ST Elevasi Miokard Infark (NSTEMI) di RSUD Dr. Moewardi. 2018.

26. Newby LK, Vora AN, Granger CB. 11 - Risk Stratification in Acute Myocardial Infarction [Internet]. Myocardial Infarction: A Companion to Braunwald’s Heart Disease. Elsevier Inc.; 2017. 114–127 p. Available from: http://dx.doi.org/10.1016/B978-0-323-35943-6.00011-6

27. Muhibbah, Wahid A, Agustiana R, Illiandri O. Karakteristik Pasien Sindrom Koroner Akut Pada Pasien Rawat Inap Ruang Tulip Di RSUD Ulin Banjarmasin. Indones J Heal Sci. 2019;3(1):6–12.

(3)

36

28. Kementrian kesehatan RI. Hasil utama riskesdas 2018. 2018;61.

29. Gayatri NI, Firmansyah S, S SH, Rudiktyo E. Prediktor mortalitas dalam rumah sakit pasien infark miokard ST elevasi ( STEMI ) akut di RSUD dr . Dradjat Prawiranegara Serang, Indonesia. Cdk. 2014;43(3):171–4.

30. Hallén J. Troponin for the estimation of infarct size: What have we learned? Cardiology. 2012;121(3):204–12.